The P-gp specific monoclonal antibody C219 was provided by Fujirebio Diagnostic Inc. (Malvern, PA), and the MRK16 antibody was purchased from Kyowa Medex Company (Tokyo, Japan). 4E3 antibody was purchased from Abcam (Cambridge, MA) and UIC2 was purchased from eBioscience (San Diego, CA) [17 (link)]. FITC-labeled anti-mouse secondary antibody IgG2aκ isotype was obtained from BD Biosciences (San Jose, CA).
Fluorescent Probes for Multidrug Resistance
The P-gp specific monoclonal antibody C219 was provided by Fujirebio Diagnostic Inc. (Malvern, PA), and the MRK16 antibody was purchased from Kyowa Medex Company (Tokyo, Japan). 4E3 antibody was purchased from Abcam (Cambridge, MA) and UIC2 was purchased from eBioscience (San Diego, CA) [17 (link)]. FITC-labeled anti-mouse secondary antibody IgG2aκ isotype was obtained from BD Biosciences (San Jose, CA).
Corresponding Organization : Center for Cancer Research
Protocol cited in 1 other protocol
Variable analysis
- Tetramethylrosamine chloride (TMR-Cl)
- BODIPY (BD)-verapamil
- 3-propionyl ethylenediamine hydrochloride (BD-EDA)
- BD-prazosin
- BD-vinblastine
- Tetramethylrhodamine ethyl ester perchlorate (TMRE)
- 3,3'-diethyloxacarbocyanine iodide (DiOC2)
- Quinolinium 6-(dimethylamino)-2-[4-[4-(dimethylamino)phenyl]-1,3-butadienyl]-1-ethyl perchlorate (LDS-751)
- SYTO13
- Rhodamine 123
- Calcein-AM
- Dihydrorhodamine 123
- Mito-tracker deep red FM
- ER tracker red
- Rhod-2-AM
- X-Rhod-1-AM
- Tetramethylrhodamine methyl ester perchlorate (TMRM)
- Rhodamine B hexyl ester
- Flutax-1
- Cyclosporine A
- NBD-cyclosporine A
- Not explicitly mentioned
- Not explicitly mentioned
- P-gp specific monoclonal antibody C219
- MRK16 antibody
- 4E3 antibody
- FITC-labeled anti-mouse secondary antibody IgG2aκ isotype
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!